137 related articles for article (PubMed ID: 7456490)
1. Biotransformation of allylbenzene analogues in vivo and in vitro through the epoxide-diol pathway.
Delaforge M; Janiaud P; Levi P; Morizot JP
Xenobiotica; 1980 Oct; 10(10):737-44. PubMed ID: 7456490
[TBL] [Abstract][Full Text] [Related]
2. Hydrolysis of the 2',3'-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases.
Luo G; Qato MK; Guenthner TM
Drug Metab Dispos; 1992; 20(3):440-5. PubMed ID: 1521503
[TBL] [Abstract][Full Text] [Related]
3. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes.
Swanson AB; Miller EC; Miller JA
Biochim Biophys Acta; 1981 Apr; 673(4):504-16. PubMed ID: 7225430
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the role of the 2',3'-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs.
Guenthner TM; Luo G
Toxicology; 2001 Mar; 160(1-3):47-58. PubMed ID: 11246123
[TBL] [Abstract][Full Text] [Related]
5. The obligatory intermediacy of 16,17 alpha- and 16,17 beta-epoxides in the biotransformation of androsta-5,16-dien-3 beta-ol to androst-5-ene-3 beta, 16 alpha, 17 beta- and -3 beta, 16 beta, 17 alpha-triols by male rat liver microsomes.
Watabe T; Komatsu T; Kobayashi K; Isobe M; Ozawa N; Saitoh Y
J Biol Chem; 1985 Jul; 260(15):8716-20. PubMed ID: 4019450
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of allylbenzene 2',3'-oxide and estragole 2',3'-oxide in the isolated perfused rat liver.
Luo G; Guenthner TM
J Pharmacol Exp Ther; 1995 Feb; 272(2):588-96. PubMed ID: 7853172
[TBL] [Abstract][Full Text] [Related]
7. The hepatic microsomal biotransformation of delta 5-steroids to 5 alpha, 6 beta-glycols via alpha- and beta-epoxides.
Watabe T; Kanai M; Isobe M; Ozawa N
J Biol Chem; 1981 Mar; 256(6):2900-7. PubMed ID: 7204381
[No Abstract] [Full Text] [Related]
8. Detoxication of the 2',3'-epoxide metabolites of allylbenzene and estragole. Conjugation with glutathione.
Luo G; Guenthner TM
Drug Metab Dispos; 1994; 22(5):731-7. PubMed ID: 7835225
[TBL] [Abstract][Full Text] [Related]
9. Epoxidation of androsta-5,16-dien-3 beta-ol by hepatic microsomal lipid peroxidation.
Watabe T; Kobayashi K; Saitoh Y; Komatsu T; Ozawa N; Tsubaki A; Endoh K; Hiratsuka A
J Biol Chem; 1986 Mar; 261(7):3200-7. PubMed ID: 3949767
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of an epoxy intermediate during the hepatic microsomal metabolism of cis-stilbene to threo-stilbene glycol due to the inhibition of epoxide hydrolase by trans-stilbenimine.
Watabe T; Akamatsu K
Biochem Pharmacol; 1974 Jul; 23(13):1845-51. PubMed ID: 4458667
[No Abstract] [Full Text] [Related]
11. Activity of liver microsomal mono-oxygenases on some epoxide-forming cyclic tricyclic drugs. I. Kinetics in vitro.
Pachecka J; Salmona M; Cantoni L; Mussini E; Pantarotto C; Frigerio A; Belvedere G
Xenobiotica; 1976 Oct; 6(10):593-8. PubMed ID: 983116
[TBL] [Abstract][Full Text] [Related]
12. The biotransformation of 1-hexadecene to carcinogenic 1,2-epoxyhexadecane by hepatic microsomes.
Watabe T; Yamada N
Biochem Pharmacol; 1975 May; 24(9):1051-3. PubMed ID: 1156447
[No Abstract] [Full Text] [Related]
13. Hepatic microsomal metabolism of 1,3-butadiene.
Malvoisin E; Roberfroid M
Xenobiotica; 1982 Feb; 12(2):137-44. PubMed ID: 7090423
[TBL] [Abstract][Full Text] [Related]
14. Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats.
Bolt HM; Schmiedel G; Filser JG; Rolzhäuser HP; Lieser K; Wistuba D; Schurig V
J Cancer Res Clin Oncol; 1983; 106(2):112-6. PubMed ID: 6630281
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the carcinogenic bifunctional olefin oxide, 4-vinyl-1-cyclohexene dioxide, by hepatic microsomes.
Watabe T; Sawahata T
Biochem Pharmacol; 1976 Mar; 25(5):601-2. PubMed ID: 942496
[No Abstract] [Full Text] [Related]
16. The metabolism of a chlorinated epoxide (MME): diol formation by pig liver microsomes.
Forrest TJ; Walker CH; Hassall KA
Biochem Pharmacol; 1979 Mar; 28(6):859-65. PubMed ID: 454483
[No Abstract] [Full Text] [Related]
17. Metabolism of some barbiturate derivatives to epoxides in rat liver microsomes.
Pachecka J; Słojkowska Z; Opioła E
Acta Pol Pharm; 1979; 36(5):613-7. PubMed ID: 44961
[No Abstract] [Full Text] [Related]
18. Metabolism of methaqualone by the epoxide-diol pathway in man and the rat.
Stillwell WG; Gregory PA; Horning MG
Drug Metab Dispos; 1975; 3(4):287-96. PubMed ID: 240659
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of chrysene and phenanthrene to bay-region diol epoxides by rat liver enzymes.
Nordqvist M; Thakker DR; Vyas KP; Yagi H; Levin W; Ryan DE; Thomas PE; Conney AH; Jerina DM
Mol Pharmacol; 1981 Jan; 19(1):168-78. PubMed ID: 7207460
[No Abstract] [Full Text] [Related]
20. Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes.
Yang SK; Bao ZP
Mol Pharmacol; 1987 Jul; 32(1):73-80. PubMed ID: 3037304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
